71 related articles for article (PubMed ID: 31037767)
21. Identification of biomarkers correlated with diagnosis and prognosis of endometrial cancer using bioinformatics analysis.
Zhao H; Jiang A; Yu M; Bao H
J Cell Biochem; 2020 Dec; 121(12):4908-4921. PubMed ID: 32692884
[TBL] [Abstract][Full Text] [Related]
22. Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis.
Lv S; Xu X; Wu Z
Oncol Lett; 2019 Dec; 18(6):6679-6689. PubMed ID: 31807178
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Expression Significance of AKT1 by Co-expression Network Analysis in Endometrial Cancer.
Huo X; Sun H; Liu Q; Ma X; Peng P; Yu M; Zhang Y; Cao D; Shen K
Front Oncol; 2019; 9():1147. PubMed ID: 31781484
[No Abstract] [Full Text] [Related]
24. Identification of key genes and pathways between type I and type II endometrial cancer using bioinformatics analysis.
Zhang K; Li H; Yan Y; Zang Y; Li K; Wang Y; Xue F
Oncol Lett; 2019 Sep; 18(3):2464-2476. PubMed ID: 31452737
[TBL] [Abstract][Full Text] [Related]
25. ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experiments.
Geng R; Zheng Y; Zhou D; Li Q; Li R; Guo X
Cancer Cell Int; 2020 Nov; 20(1):542. PubMed ID: 33292231
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer.
Li Y; Li L
BMC Genet; 2020 Sep; 21(1):113. PubMed ID: 32962636
[TBL] [Abstract][Full Text] [Related]
27. Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer.
Bradfield A; Button L; Drury J; Green DC; Hill CJ; Hapangama DK
Methods Protoc; 2020 Sep; 3(3):. PubMed ID: 32899298
[TBL] [Abstract][Full Text] [Related]
28. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics Analysis of Global Proteomic and Phosphoproteomic Data Sets Revealed Activation of NEK2 and AURKA in Cancers.
Deb B; Sengupta P; Sambath J; Kumar P
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033228
[TBL] [Abstract][Full Text] [Related]
30. Multi-omics profiling reveals distinct microenvironment characterization of endometrial cancer.
Cai Y; Chang Y; Liu Y
Biomed Pharmacother; 2019 Oct; 118():109244. PubMed ID: 31352239
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the circular RNA transcriptome in the grade 3 endometrial cancer.
Ye F; Tang QL; Ma F; Cai L; Chen M; Ran XX; Wang XY; Jiang XF
Cancer Manag Res; 2019; 11():6215-6227. PubMed ID: 31308756
[TBL] [Abstract][Full Text] [Related]
32. Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data.
Huo X; Sun H; Cao D; Yang J; Peng P; Yu M; Shen K
Sci Rep; 2019 Jul; 9(1):9924. PubMed ID: 31289358
[TBL] [Abstract][Full Text] [Related]
33. Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer.
Liu L; Lin J; He H
Front Genet; 2019; 10():373. PubMed ID: 31105744
[TBL] [Abstract][Full Text] [Related]
34. Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach.
Taylor AH; Konje JC; Ayakannu T
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760635
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of E2F1 in the proliferation, migration, and invasion of endometrial carcinoma cells via the regulation of BMI1 transcription.
Lu Y; Wei Y; Shen X; Tong Y; Lu J; Zhang Y; Ma Y; Zhang R
Genes Genomics; 2023 Nov; 45(11):1423-1431. PubMed ID: 37646913
[TBL] [Abstract][Full Text] [Related]
36. Excavation of Molecular Subtypes of Endometrial Cancer Based on DNA Methylation.
Liu Y; Gu Y; Zhang M; Zeng J; Wang Y; Wang H; Liu X; Liu S; Wang Z; Wang Y; Wang L; Zhang Y
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421781
[TBL] [Abstract][Full Text] [Related]
37. Endothelial cell-specific molecule 1 (ESM1) promoted by transcription factor SPI1 acts as an oncogene to modulate the malignant phenotype of endometrial cancer.
He Y; Lin L; Ou Y; Hu X; Xu C; Wang C
Open Med (Wars); 2022; 17(1):1376-1389. PubMed ID: 36117773
[TBL] [Abstract][Full Text] [Related]
38. Identification of prognostic long intergenic non-coding RNAs as competing endogenous RNAs with KRAS mutations in colorectal cancer.
Xu J; Huang QY; Ge CJ
Oncol Lett; 2021 Oct; 22(4):717. PubMed ID: 34429757
[TBL] [Abstract][Full Text] [Related]
39. A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation.
Yang X; Cheng Y; Li X; Zhou J; Dong Y; Shen B; Zhao L; Wang J
Onco Targets Ther; 2021; 14():2579-2598. PubMed ID: 33880037
[TBL] [Abstract][Full Text] [Related]
40. [Advancement of E2F1 in Common Tumors].
Shen C; Li J; Chang S; Che G
Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):921-926. PubMed ID: 33070516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
